Nomination committee

The duties of the Nomination committee include preparing and drafting of proposals for election and remuneration to the chairman of the board, members of the board of directors, committee members and auditors, the most recently proposed by the Audit Committee.

The members of the nomination committee must safeguard the interests of all shareholders and not unduly disclose what has occurred in the nomination committee’s work. The chairman of the board or any other board member shall not chair the nomination committee.

The nomination committee meets if necessary, but at least once a year. The term of office for the appointed nomination committee shall run until a new nomination committee is appointed. At least six months before the AGM, the members of the nomination committee shall be announced on Isofol’s website.

In accordance with the principles for the appointment of the nomination committee of Isofol Medical AB (publ) adopted at the annual general meeting 2025, the nomination committee for the annual general meeting 2026 shall consist of  three members of representatives appointed by the three largest shareholders in the company for the number of votes at September 30, 2025. Another nomination committee member may be appointed by minority shareholders representing at least 10 percent of the votes based on the share register provided by Euroclear Sweden AB or other reliable information. 

The term of office for the nomination committee shall run until a new nomination committee is appointed.

The nomination committee ahead of the AGM 2026 consists of the following members

• Christian Haglund, representing approximately 4.72 percent of the shares and votes,
• Johan Möller, chairman of the nomination committee, appointed by Hans Enocson representing approximately 2.70 percent of the shares and votes,
• Göran Gustafsson, representing approximately 2.17 percent of the shares and votes, and
• Lars Lind, representatives of minority owners representing about 14.13 percent of the shares and votes

The members of the nomination committee are appointed by owners who represent a total of approximately 23.72 percent of the total number of shares and votes in Isofol according to the ownership conditions as of September 30, 2025.

Shareholders who wish to submit proposals to the nomination committee shall do this in writing by sending an e-mail to valberedningen@isofolmedical.com (heading: “Isofol’s nomination committee”) or by mail to the following address:

Isofol Medical AB (publ)
Att. Valberedningen
Arvid Wallgrens Backe 20
S-413 46  GOTHENBURG
SWEDEN

Any proposals must be received by the nomination committee no later than February 28, 2026, to be included in the notice and agenda for the Annual General Meeting 2026.

The Annual General Meeting in Isofol Medical AB (publ) will be held on May 19, 2026, in Gothenburg.

Principles